Human Thrombin Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product (Bovine Thrombin, Human Thrombin, Recombinant Thrombin); Dosage Form (Powder Form, Solution Form, Others); End User (Hospitals, Diagnostics Centers and Clinics, Academics and Research Institutes)

Report Code: TIPRE00008178 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Thrombin is a serine protease enzyme that is encoded by a particular gene named F2 and is used to convert soluble fibrinogen into insoluble fibrin. Human thrombin is a sterile solution, having pH 6.8-7.2, containing highly purified human thrombin for the activation of clotting. It is used in various medical surgeries in the management of uncontrolled bleeding. R&D applications include several research activities such as protein-structure analysis, in vitro study, coagulation research, biochemical research, and medical research.

MARKET DYNAMICS

The human thrombin market is anticipated to rise in adoption in various research and diagnostic applications. However, the increasing hemostatic use of thrombin-based products during surgeries has driven the demand for thrombin in the hospital segment. Moreover, the growing adoption of hemostats in excessive bleeding during the surgical procedure is expected to benefit the growth of the market in the forecast period.

MARKET SCOPE

The "Human Thrombin Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in human thrombin market with detailed market segmentation by product, dosage form, end user and geography. The human thrombin market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in human thrombin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The human thrombin market is segmented on the basis of product, dosage form and end user. Based on product the market is segmented as bovine thrombin, human thrombin and recombinant thrombin. On the basis of dosage form the market is categorized as powder form, solution form and others. On the basis of end user the market is categorized as hospitals, diagnostics centers & clinics and academics and research institutes.



Get more information on this report :

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in human thrombin market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The human thrombin market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting human thrombin market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human thrombin market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in human thrombin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in human thrombin market are anticipated to have lucrative growth opportunities in the future with the rising demand for in human thrombin market in the global market. Below mentioned is the list of few companies engaged in the human thrombin market.

The report also includes the profiles of key in human thrombin market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  AMRESCO Inc.
  •  Baxter International, Inc.
  •  Bayer AG
  •  BD Biosciences
  •  CSL Behring
  •  Life Technologies Corporation
  •  Pfizer Inc.
  •  PromoCell GmbH
  •  Sigma-Aldrich Corporation
  •  Vitrolife AB
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Thrombin Market - By Product
1.3.2 Human Thrombin Market - By Dosage Form
1.3.3 Human Thrombin Market - By End User
1.3.4 Human Thrombin Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. HUMAN THROMBIN MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HUMAN THROMBIN MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. HUMAN THROMBIN MARKET - GLOBAL MARKET ANALYSIS

6.1. HUMAN THROMBIN - GLOBAL MARKET OVERVIEW
6.2. HUMAN THROMBIN - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. HUMAN THROMBIN MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT

7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BOVINE THROMBIN
7.3.1. Overview
7.3.2. Bovine Thrombin Market Forecast and Analysis
7.4. HUMAN THROMBIN
7.4.1. Overview
7.4.2. Human Thrombin Market Forecast and Analysis
7.5. RECOMBINANT THROMBIN
7.5.1. Overview
7.5.2. Recombinant Thrombin Market Forecast and Analysis

8. HUMAN THROMBIN MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM

8.1. OVERVIEW
8.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
8.3. POWDER FORM
8.3.1. Overview
8.3.2. Powder Form Market Forecast and Analysis
8.4. SOLUTION FORM
8.4.1. Overview
8.4.2. Solution Form Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. HUMAN THROMBIN MARKET - REVENUE AND FORECASTS TO 2027 - END USER

9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. DIAGNOSTICS CENTERS AND CLINICS
9.4.1. Overview
9.4.2. Diagnostics Centers and Clinics Market Forecast and Analysis
9.5. ACADEMICS AND RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Academics and Research Institutes Market Forecast and Analysis

10. HUMAN THROMBIN MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

10.1. NORTH AMERICA
10.1.1 North America Human Thrombin Market Overview
10.1.2 North America Human Thrombin Market Forecasts and Analysis
10.1.3 North America Human Thrombin Market Forecasts and Analysis - By Product
10.1.4 North America Human Thrombin Market Forecasts and Analysis - By Dosage Form
10.1.5 North America Human Thrombin Market Forecasts and Analysis - By End User
10.1.6 North America Human Thrombin Market Forecasts and Analysis - By Countries
10.1.6.1 United States Human Thrombin Market
10.1.6.1.1 United States Human Thrombin Market by Product
10.1.6.1.2 United States Human Thrombin Market by Dosage Form
10.1.6.1.3 United States Human Thrombin Market by End User
10.1.6.2 Canada Human Thrombin Market
10.1.6.2.1 Canada Human Thrombin Market by Product
10.1.6.2.2 Canada Human Thrombin Market by Dosage Form
10.1.6.2.3 Canada Human Thrombin Market by End User
10.1.6.3 Mexico Human Thrombin Market
10.1.6.3.1 Mexico Human Thrombin Market by Product
10.1.6.3.2 Mexico Human Thrombin Market by Dosage Form
10.1.6.3.3 Mexico Human Thrombin Market by End User
10.2. EUROPE
10.2.1 Europe Human Thrombin Market Overview
10.2.2 Europe Human Thrombin Market Forecasts and Analysis
10.2.3 Europe Human Thrombin Market Forecasts and Analysis - By Product
10.2.4 Europe Human Thrombin Market Forecasts and Analysis - By Dosage Form
10.2.5 Europe Human Thrombin Market Forecasts and Analysis - By End User
10.2.6 Europe Human Thrombin Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Human Thrombin Market
10.2.6.1.1 Germany Human Thrombin Market by Product
10.2.6.1.2 Germany Human Thrombin Market by Dosage Form
10.2.6.1.3 Germany Human Thrombin Market by End User
10.2.6.2 France Human Thrombin Market
10.2.6.2.1 France Human Thrombin Market by Product
10.2.6.2.2 France Human Thrombin Market by Dosage Form
10.2.6.2.3 France Human Thrombin Market by End User
10.2.6.3 Italy Human Thrombin Market
10.2.6.3.1 Italy Human Thrombin Market by Product
10.2.6.3.2 Italy Human Thrombin Market by Dosage Form
10.2.6.3.3 Italy Human Thrombin Market by End User
10.2.6.4 Spain Human Thrombin Market
10.2.6.4.1 Spain Human Thrombin Market by Product
10.2.6.4.2 Spain Human Thrombin Market by Dosage Form
10.2.6.4.3 Spain Human Thrombin Market by End User
10.2.6.5 United Kingdom Human Thrombin Market
10.2.6.5.1 United Kingdom Human Thrombin Market by Product
10.2.6.5.2 United Kingdom Human Thrombin Market by Dosage Form
10.2.6.5.3 United Kingdom Human Thrombin Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Human Thrombin Market Overview
10.3.2 Asia-Pacific Human Thrombin Market Forecasts and Analysis
10.3.3 Asia-Pacific Human Thrombin Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Human Thrombin Market Forecasts and Analysis - By Dosage Form
10.3.5 Asia-Pacific Human Thrombin Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Human Thrombin Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Human Thrombin Market
10.3.6.1.1 Australia Human Thrombin Market by Product
10.3.6.1.2 Australia Human Thrombin Market by Dosage Form
10.3.6.1.3 Australia Human Thrombin Market by End User
10.3.6.2 China Human Thrombin Market
10.3.6.2.1 China Human Thrombin Market by Product
10.3.6.2.2 China Human Thrombin Market by Dosage Form
10.3.6.2.3 China Human Thrombin Market by End User
10.3.6.3 India Human Thrombin Market
10.3.6.3.1 India Human Thrombin Market by Product
10.3.6.3.2 India Human Thrombin Market by Dosage Form
10.3.6.3.3 India Human Thrombin Market by End User
10.3.6.4 Japan Human Thrombin Market
10.3.6.4.1 Japan Human Thrombin Market by Product
10.3.6.4.2 Japan Human Thrombin Market by Dosage Form
10.3.6.4.3 Japan Human Thrombin Market by End User
10.3.6.5 South Korea Human Thrombin Market
10.3.6.5.1 South Korea Human Thrombin Market by Product
10.3.6.5.2 South Korea Human Thrombin Market by Dosage Form
10.3.6.5.3 South Korea Human Thrombin Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Human Thrombin Market Overview
10.4.2 Middle East and Africa Human Thrombin Market Forecasts and Analysis
10.4.3 Middle East and Africa Human Thrombin Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Human Thrombin Market Forecasts and Analysis - By Dosage Form
10.4.5 Middle East and Africa Human Thrombin Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Human Thrombin Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Human Thrombin Market
10.4.6.1.1 South Africa Human Thrombin Market by Product
10.4.6.1.2 South Africa Human Thrombin Market by Dosage Form
10.4.6.1.3 South Africa Human Thrombin Market by End User
10.4.6.2 Saudi Arabia Human Thrombin Market
10.4.6.2.1 Saudi Arabia Human Thrombin Market by Product
10.4.6.2.2 Saudi Arabia Human Thrombin Market by Dosage Form
10.4.6.2.3 Saudi Arabia Human Thrombin Market by End User
10.4.6.3 U.A.E Human Thrombin Market
10.4.6.3.1 U.A.E Human Thrombin Market by Product
10.4.6.3.2 U.A.E Human Thrombin Market by Dosage Form
10.4.6.3.3 U.A.E Human Thrombin Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Human Thrombin Market Overview
10.5.2 South and Central America Human Thrombin Market Forecasts and Analysis
10.5.3 South and Central America Human Thrombin Market Forecasts and Analysis - By Product
10.5.4 South and Central America Human Thrombin Market Forecasts and Analysis - By Dosage Form
10.5.5 South and Central America Human Thrombin Market Forecasts and Analysis - By End User
10.5.6 South and Central America Human Thrombin Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Human Thrombin Market
10.5.6.1.1 Brazil Human Thrombin Market by Product
10.5.6.1.2 Brazil Human Thrombin Market by Dosage Form
10.5.6.1.3 Brazil Human Thrombin Market by End User
10.5.6.2 Argentina Human Thrombin Market
10.5.6.2.1 Argentina Human Thrombin Market by Product
10.5.6.2.2 Argentina Human Thrombin Market by Dosage Form
10.5.6.2.3 Argentina Human Thrombin Market by End User

11. INDUSTRY LANDSCAPE

11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. HUMAN THROMBIN MARKET, KEY COMPANY PROFILES
12.1. AMRESCO INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BAXTER INTERNATIONAL, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAYER AG
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BD BIOSCIENCES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CSL BEHRING
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. LIFE TECHNOLOGIES CORPORATION
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. PFIZER INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. PROMOCELL GMBH
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SIGMA-ALDRICH CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. VITROLIFE AB
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX

13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AMRESCO Inc.
2. Baxter International, Inc.
3. Bayer AG
4. BD Biosciences
5. CSL Behring
6. Life Technologies Corporation
7. Pfizer Inc.
8. PromoCell GmbH
9. Sigma-Aldrich Corporation
10. Vitrolife AB
TIPRE00008178
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking